Intersternocostoclavicular ossification' 2 is a benign orthopaedic disorder of the upper anterior chest wall. Known also as sternocostoclavicular hyperostosis,3 it is characterised by inflammatory ossification of the joints and hyperostosis of the surrounding bones. Judging from the common association of this ossification with palmoplantar pustulosis,4 5 the 'focal infection' mechanism postulated in palmoplantar pustulosis6 7 might also play a part in the pathogenesis of this joint disease. Antibiotics, however, are usually ineffective on the joint symptoms-namely, focal pain, swelling, and restriction of motion.2 The pathophysiology of intersternocostoclavicular ossification is still to be clarified, and no specific treatment has yet been established for this disorder. Usually, nonsteroidal anti-inflammatory agents are prescribed, but these provide little relief for severely affected patients. We report two patients in the exacerbation phase of typical intersternocostoclavicular ossification who were successfully treated with intramuscular injections of a calcitonin analogue. The patient, a 45 year old man, had a history of severe head injury sustained in a traffic accident about 20 years previously, from which he recovered. For five years he had had mild but persistent pain in his shoulders and the back of his neck, which increased in December 1986 causing sleep loss and restricted motion. When he visited our clinic the skin on the upper anterior chest was reddish with localised heat. There was also slight swelling and severe percussion pain in the region. During the previous year he had noticed pustules on his palms, which had caused neither pain nor itching, and similar lesions on the soles of his feet were found on physical examination. The radiograph and radiophosphonate scintiscan (figs 1 and 2) were characteristic of intersternocostoclavicular ossification,2 9 10 and he was admitted to hospital. Laboratory data suggested chronic active inflammation together with mild liver dysfunction. Isoenzyme analysis of alkaline phosphatase showed increases of both skeletal and hepatic components. A bone biopsy specimen taken at the medial portion of the left clavicle showed non-suppurative chronic inflammation of bone marrow with prominent periosteal hyperostosis, thus confirming the diagnosis histopathologically.2 5 At the same time the results of a microscopic study of the skin biopsy specimen were compatible with palmoplantar pustulosis.
Intersternocostoclavicular ossification' 2 is a benign orthopaedic disorder of the upper anterior chest wall. Known also as sternocostoclavicular hyperostosis,3 it is characterised by inflammatory ossification of the joints and hyperostosis of the surrounding bones. Judging from the common association of this ossification with palmoplantar pustulosis,4 5 the 'focal infection' mechanism postulated in palmoplantar pustulosis6 7 might also play a part in the pathogenesis of this joint disease. Antibiotics, however, are usually ineffective on the joint symptoms-namely, focal pain, swelling, and restriction of motion. 2 The pathophysiology of intersternocostoclavicular ossification is still to be clarified, and no specific treatment has yet been established for this disorder. Usually, nonsteroidal anti-inflammatory agents are prescribed, but these provide little relief for severely affected patients. We report two patients in the exacerbation phase of typical intersternocostoclavicular ossification who were (fig 2) , and the ratio of uptake per pixel in these two regions was calculated. From a previous basic evaluation of the reproducibility a change in this uptake ratio of more than 20% was deemed significant. In this patient more than 50% reduction was seen after the first month of treatment with calcitonin analogue, though the abnormal uptake was still visually prominent in scintigraphic images. Despite these improvements, values and titres of serological markers remained high, with a relapse of palmoplantar pustulosis, which had previously been effectively treated with a corticosteroid ointment after the histological diagnosis. Injection of the calcitonin analogue was stopped after the ninth week, and oral colchicine was started at 0 5 mg twice daily, which normalised these indices and improved the skin pustules. Unfortunately, the occurrence of abdominal pain after four weeks' treatment with colchicine necessitated reduction of the dose to 0 5 mg daily, which caused increased abnormalities in laboratory data but not the dermatological lesions. Colchicine was discontinued after another 12 months, and this was associated with gradual improvement in serological values. During and after the colchicine regimen joint symptoms were well controlled with nonsteroidal anti-inflammatory drugs, except for occasional episodes of minor left clavicular pain. CASE 2 A 67 year old housewife was referred to our clinic for detailed examination of her right clavicle, in which she had had pain for 20 years. Three years previously she had undergone surgical curettage of the clavicle under the diagnosis of 'osteomyelitis', and thereafter had been treated continuously with several oral antibiotics, which had little effect. She had a past history of tonsillitis in her childhood but lacked the skin lesions of palmoplantar pustulosis. Upon presentation venous dilatation was seen in the skin overlying the left clavicle, together with a percussion pain of the upper anterior chest wall. Unlike case 1 the laboratory data (table 2) were not remarkable, and serological tests for streptococcal antigens were negative. Radiological and scintigraphic findings were typical of intersternocostoclavicular ossification as in case 1, and the diagnosis was confirmed histologically by a review of the specimen taken during a previous operation. Intense uptake oftechnetium-99m hydroxymethylenediphosphonate was noted at the hyperostotic regions seen in the radiogram. Radioactivity in the right second rib and the whole sternum was also mildly increased. The numbered squares indicate regions ofinterestfor the quantitative assessment ofabnormal uptake. In this scintigram the ratio of countlpixel ofa diseased bone (region 2) to that ofa normal reference area (region 1) was 7-6. Having noted the close association between intersternocostoclavicular ossification and palmoplantar pustulosis, Sonozaki and colleagues proposed the term pustulotic arthroosteitis (PAO),4 suggesting a common cause for these two conditions. They analysed clinical features of accumulated cases and suggested that pustulotic arthro-osteitis was a seronegative spondyloarthritis.5 There are a significant minority of patients with intersternocostoclavicular ossification without palmoplantar pustulosis, however, as in case 2, whose symptoms and radiographic features are indistinguishable from those of patients with palmoplantar pustulosis. Interestingly, patient 2 did not have raised titres of antistreptolysin 0 and antistreptokinase, whereas patient 1 (with palmoplantar pustulosis) did, suggesting that other factors besides focal infection may play a part in the pathogenesis of intersternocostoclavicular ossification, at least in cases without palmoplantar pustulosis. In fact, the raised titres of these antistreptococcal antibodies in patient 1 might have simply reflected an anamnestic response to chronic inflammation, either in his liver, skin, or bone and joint. In any case our experience in these two cases showed that injection of calcitonin analogue produced symptomatic relief in the acutely exacerbated clinical situations regardless of the associated skin disease. Thus the hormone must have exerted its effects by mechanisms not directly related to the putative common causenamely, focal infection.
The failure of treatment by calcitonin nasal spray in case 2 might have been due to insufficient drug delivery. When the patient was examined in an otolaryngology clinic she was found to have chronic sinusitis, which might have led to reduced absorption of the hormone through nasal mucosa. Furthermore, if a spray were used in the future for patients without mucosal problems it would be necessary to determine the size of the nasal dose required to exert effects equivalent to those of the agent given intramuscularly.
Theoretically colchicine might have suppressed the inflammation of bones and joints, as in gout,"1 but it was found not to reduce the pain of intersternocostoclavicular ossification. On the other hand, the drug has been used successfully for palmoplantar pustulosis,22 presumably owing to its inhibitory effects on leucocytes. In case 1, it certainly cured the skin lesion and lowered the inflammatory indices and titres of antistreptococcal antibodies.
Long term calcitonin treatment can be hindered by a so called 'escape' phenomenon,23 24 though this was not found in our cases. As the severity of symptoms in intersternocostoclavicular ossification is known to fluctuate naturally, however, an escape could be avoided by using calcitonin injections only during the waxing phase. Clinically, this would mean trying to discontinue the hormone after several months of the regimen, just as was done in the two cases reported here. After a period without calcitonin the responsiveness of target organs should be restored, and if symptoms reoccur they could be quelled again with the same regimen.
To conclude, our initial encouraging results warrant further use of calcitonin injections in cases of acute aggravation of intersternocostoclavicular ossification. In due course accumulated clinical data from a larger number of patients should help to clarify both the pathogenesis of the disease and the mechanism of action of the drug.
